Avanos Medical AVNS Business Segments
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| Reportable segment operating income (loss) by Business | ||||||
| PM&R | -$1.8M-135% | $5.2M+160% | $2M+11.1% | $1.8M+800% | $200K-94.9% | |
| Total Specialty Nutrition Systems | $23.1M+12.7% | $20.5M-10.9% | $23M+27.8% | $18M-14.7% | $21.1M-15.6% | |
| Other segment items by Business | ||||||
| PM&R | $0+100% | -$100K— | $0— | $0— | $0— | |
| Total Specialty Nutrition Systems | -$100K— | —— | -$400K-300% | $200K+300% | -$100K— | |
| General expenses by Business | ||||||
| PM&R | -$12.3M-12.8% | -$10.9M+6.0% | -$11.6M+12.8% | -$13.3M-4.7% | -$12.7M-51.2% | |
| Total Specialty Nutrition Systems | -$20.8M-28.4% | -$16.2M+7.4% | -$17.5M+4.4% | -$18.3M-4.6% | -$17.5M-44.6% | |
| Currency translation adjustment by Business | ||||||
| PM&R | -$900K-213% | $800K-81.8% | $4.4M+291% | -$2.3M-667% | -$300K— | |
| Total Specialty Nutrition Systems | $0— | $0— | $0— | $0— | $0— | |
| Advertising, promotion and selling expenses by Business | ||||||
| PM&R | -$15.9M+1.2% | -$16.1M-3.9% | -$15.5M+1.9% | -$15.8M-6.0% | -$14.9M+25.1% | |
| Total Specialty Nutrition Systems | -$15.1M+4.4% | -$15.8M-18.8% | -$13.3M-4.7% | -$12.7M-7.6% | -$11.8M+35.2% | |
| Cost of goods sold by Business | ||||||
| PM&R | -$21.7M-4.3% | -$20.8M+5.0% | -$21.9M+1.8% | -$22.3M-7.7% | -$20.7M+1.9% | |
| Total Specialty Nutrition Systems | -$48M-2.6% | -$46.8M-5.6% | -$44.3M-14.2% | -$38.8M-10.2% | -$35.2M+2.8% | |
| Depreciation and amortization expense by Business | ||||||
| PM&R | -$3.7M-2.8% | -$3.6M0.0% | -$3.6M0.0% | -$3.6M+7.7% | -$3.9M-18.2% | |
| Total Specialty Nutrition Systems | -$6.1M-5.2% | -$5.8M-16.0% | -$5M-8.7% | -$4.6M+8.0% | -$5M-35.1% | |
| Distribution by Business | ||||||
| PM&R | -$3.2M+13.5% | -$3.7M-19.4% | -$3.1M0.0% | -$3.1M-14.8% | -$2.7M+10.0% | |
| Total Specialty Nutrition Systems | -$7.1M-12.7% | -$6.3M-3.3% | -$6.1M+1.6% | -$6.2M+1.6% | -$6.3M0.0% | |
| Research and development expenses by Business | ||||||
| PM&R | -$1.3M0.0% | -$1.3M0.0% | -$1.3M-18.2% | -$1.1M0.0% | -$1.1M+8.3% | |
| Total Specialty Nutrition Systems | -$3.7M+5.1% | -$3.9M+11.4% | -$4.4M-2.3% | -$4.3M-4.9% | -$4.1M+6.8% | |
| Goodwill by Business | ||||||
| PM&R | $52.7M-1.7% | $53.6M+1.5% | $52.8M-1.5% | $53.6M-58.2% | $128.3M+0.2% | |
| Total Specialty Nutrition Systems | $341.3M0.0% | $341.3M-0.1% | $341.6M+4.3% | $327.6M0.0% | $327.6M0.0% | |
| Net Sales by Product | ||||||
| Enteral feeding | $84.6M+1.9% | $83M+0.4% | $82.7M+11.0% | $74.5M0.0% | $74.5M-0.7% | |
| Neonate solutions | $39.4M+22.7% | $32.1M+2.6% | $31.3M+11.0% | $28.2M+6.0% | $26.6M-13.9% | |
| Radiofrequency ablation | $34.5M-6.5% | $36.9M+6.6% | $34.6M-3.4% | $35.8M+12.9% | $31.7M-7.0% | |
| Surgical pain and recovery | $21.8M-11.7% | $24.7M+1.2% | $24.4M-3.2% | $25.2M+2.9% | $24.5M-8.2% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How does Avanos Medical break its business down?
- Avanos Medical (AVNS) reports reportable segment operating income (loss) by business across 2 parts — PM&R and Total Specialty Nutrition Systems. Each is extracted from the segment footnotes and tracked over time.
- Where does Avanos Medical's segment data come from?
- Segment breakdowns are pulled from the segment footnotes in Avanos Medical's SEC filings (the XBRL dimensional tags), so every line ties back to a reported figure. Switch between quarterly, annual, and TTM, or open any segment for its full history.
